Have the recently completed phase III trials significantly impacted adjuvant treatment choices for stage II breast carcinoma?
Middleman
E
E
Cancer Center Methodist Hospitals of Dallas, TX, USA.
Castro
M P
MP
Gradishar
W
W
D001943:Breast Neoplasms / Q000628:therapy*; D017326:Clinical Trials, Phase III as Topic; D003131:Combined Modality Therapy; D003657:Decision Making; D006801:Humans